BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 21, 2008
View Archived Issues
Hydrogen peroxide scavenging prolongs life span in experimental Friedreich's ataxia
Read More
Targeting specific GABA-A receptor subunits shows potential in treating chronic pain
Read More
Preliminary safety and tolerability data reported from phase I MRX-4 study
Read More
Nymox to report results of new phase II study of NX-1207 in BPH
Read More
FDA grants authorization to Arpida for phase II trial of iclaprim in cSSSI
Read More
BioInvent receives Danish approval to initiate phase I clinical trial of BI-204
Read More
Medicure announces second quarter fiscal 2008 results
Read More
FDA places clinical hold on YM BioSciences' phase II AP5 study of AeroLEF for pain
Read More
Cogentus initiates CG106 clinical study to examine antiplatelet activity of CGT-2168
Read More
Karo Bio reports positive results from phase IIb study of eprotirome
Read More
Flanders government awards grant to Galapagos for RA drug development
Read More
Henderson Morley and the ACVD enter agreement for cytomegalovirus vaccine
Read More
QLT restructures company and puts Eligard, Aczone and Atrigel up for sale
Read More
Roche extends tender offer for Ventana until March 2008
Read More
Boehringer completes enrollment in RE-LY trial of Pradaxa for atrial fibrillation
Read More
Regeneration and Tutogen change name to RTI Biologics following merger
Read More
FDA grants SPA approval to Agennix for phase III trial of talactoferrin alfa for NSCLC
Read More
GM-CSF disclosed as target of MorphoSys' MOR-103 program for RA
Read More
Synvista and Novel Therapeutic Technologies enter agreement for ALT-2074 for psoriasis
Read More
FDA approves single tablet combination of Tekturna and diuretic in hypertension
Read More
FDA approves Abbott's Humira for moderate to severe chronic plaque psoriasis
Read More
FDA grants Intelence accelerated approval for HIV combination therapy
Read More
FDA approves Welchol for glucose reduction in adults with type 2 diabetes
Read More
Novel treatments for musculoskeletal and connective tissue disorders described in patent literature
Read More
Recent Sia Peptides patent discloses new stress-relieving agents
Read More
Recent patents disclose novel antiinfective agents
Read More